In partnership with

SenJam's Campaign on Wefunder

Company Overview: SenJam Pharmaceuticals aims to revolutionize the treatment of inflammation, targeting its root causes rather than merely masking symptoms. They strive to create safe, potent, and non-toxic anti-inflammatory treatments by repurposing FDA-approved small molecules. Their innovative approach promises to address numerous conditions caused by inflammation, such as diabetes, cancer, respiratory infections, arthritis, and hangovers.

Key Highlights:

• VC-Backed: SenJam has raised over $250k from venture firms.

• Experienced Leadership: The team boasts over $730 million in exits and expertise from MIT, Harvard, Mayo Clinic, and Memorial Sloan Kettering.

• Patent Portfolio: They hold over 60 global patents and have 11 assets in their pipeline, with four near pivotal Phase 2 clinical trials.

• Innovative Treatments: Their flagship products include a potential FDA-approved hangover cure and a therapeutic for opioid withdrawal.

Investment Terms:

• Convertible Note: $80 million valuation cap with a 20% discount for early bird investors.

• Minimum Investment: $250.

• Investor Perks: Include dividends from the 22-patent portfolio, equity, and potential royalties.

Team and Vision:

• Leadership: Co-founded by Jim Iversen and Jackie Iversen, who bring extensive experience in scaling companies and clinical pain management.

• Mission: To treat inflammation at its source, preventing disease progression and improving overall health and longevity.

Product Development:

• Clinical Trials: Three key assets are at critical Phase 2 trials with partners like KVK Tech, People Science, and Duke University.

• Mechanism of Action: Their treatments modulate cytokines to prevent acute inflammation from becoming chronic, reducing the risk of tissue damage and disease.

Market Opportunity:

• The Anti-Inflammatory Drugs Market is valued at $111 billion and growing at a 9.3% CAGR. SenJam aims to capture a larger $217 billion opportunity.

• Revenue Model: Licensing their intellectual property, including milestone and royalty payments.

Call to Action:

• Investment Opportunity: SenJam invites investors to join their mission of creating "Pharma for the People" by investing in their transformative approach to health.

Campaign Vision: SenJam envisions a world where inflammation is controlled at its source, extending the health span and vitality of billions of people. They are committed to changing how the pharmaceutical industry treats humanity, making treatments more accessible and effective.

For more details and to invest, visit the SenJam campaign on Wefunder.

Invest in Community and Culture: Spotlight on Bump 'n Grind

Transforming Coffee, Music, and Community

Bump 'n Grind is not your typical coffee shop at the heart of Silver Spring, MD. This innovative business seamlessly blends high-quality coffee, vibrant music, and a strong sense of community to create a unique cultural hub. With a mission to foster genuine connections and enrich lives locally and globally, Bump 'n Grind is setting a new standard for community spaces.

Why Invest in Bump 'n Grind?

Community Impact: Bump 'n Grind is committed to being more than just a place to grab a coffee. They meticulously source and roast what they define as conscientious coffee, ensuring ethical and sustainable practices. By hosting weekly music sessions and operating a thriving record label, they amplify the cultural heartbeat of their community.

Financials and Terms:

• Funding Goal: $35,000 to $65,000

• Interest Rate: 12.5%

• Investment Type: Debt

• Loan Term: 36 months

• Amount Raised: $34,301 from 38 investors

• Time Left: 19 days

Innovative Approach: Bump 'n Grind creates quintessential third spaces within neighborhood settings, offering more than just a venue but a place where people feel they belong. Their multifaceted offerings and commitment to cultural enrichment make them a positive force locally and globally.

The Opportunity

Bump 'n Grind offers debt-based securities under Regulation CF through Honeycomb Portal LLC. With a compelling interest rate of 12.5% and a 36-month loan term, this investment promises potential returns and supports a business dedicated to ethical practices and community enrichment.

Join the Movement

Investing in Bump 'n Grind is more than a financial decision—it's a chance to be part of a movement that values community, culture, and conscientious commerce. By supporting their mission, investors can help create vibrant spaces that foster genuine human connections.

Visit the Bump 'n Grind campaign on Honeycomb Credit to learn more and invest today. Together, we can help Bump 'n Grind brew a better world.

Disclaimer: Investing in private businesses involves risks, including loss of investment, illiquidity, and dilution. This communication is not an offer to sell or a solicitation of an offer to buy securities. All information provided herein is for informational purposes only and should not be relied upon as legal, business, or tax advice. Please review the offering documents on the campaign page for full details before making an investment decision.

Invest in the Future of Online Horticulture: Spotlight on Lively Root

Revolutionizing Plant Shopping with Sustainability and Innovation

Imagine a world where the perfect plant is just a click away, arriving at your doorstep with the utmost care and sustainability. Lively Root, based in San Diego, CA, is making this a reality. By bridging the gap between nurseries and consumers, Lively Root offers an unparalleled online plant shopping experience that is both efficient and eco-friendly.

Why Lively Root Stands Out

Sustainable Solutions: Lively Root is committed to sustainability. It utilizes advanced technology and proprietary packaging to ensure plants are shipped safely and cost-effectively across all 48 contiguous states. Its vertically integrated model allows it to maintain competitive pricing while delivering high-quality products.

Impressive Metrics:

• Lifetime Revenue: $1.22 million

• Customer Base: 500,000 satisfied customers nationwide

• B2B Clients: Prestigious partnerships with Apple, Airbnb, LinkedIn, Oracle, and more

• Exclusive Collaboration: Petco’s sole provider of pet-friendly plants

Financial Details:

• Funding Goal: $200,000

• Minimum Investment: $100

• Investment Terms: Future equity with a $9 million valuation cap and a 20% discount for early-bird investors

• Current Investment: $66,500 raised from enthusiastic backers

Leadership and Expertise:

• Colin Barceloux (CEO): A proven entrepreneur and Y Combinator alum, leading Lively Root with visionary expertise.

• Brian Bates (Business Development): Known for implementing scalable and repeatable sales processes to drive growth.

• Anurag Grover (Engineering): Bringing over 15 years of programming and startup experience to ensure technological excellence.

Investing in Growth and Innovation

Lively Root is not just about selling plants; it's about creating a personalized and engaging plant-buying experience. Their custom technology solutions and proprietary packaging ensure that plants arrive healthy and thriving, regardless of the weather conditions. With a robust fulfillment system, they are poised to capture a significant share of the booming online plant market.

Join the movement and invest in a company dedicated to sustainability, innovation, and exceptional customer experience.

Visit the Lively Root campaign on Wefunder to learn more and become part of this green revolution.

12 Reasons To Look at Avawatz's

Avawatz is not just a company; it is a pioneer in the field of AI robotics

Read the Full Article

Steal our best value stock ideas.

PayPal, Disney, and Nike all dropped 50-80% recently from all-time highs.

Are they undervalued? Can they turn around? What’s next? You don’t have time to track every stock, but should you be forced to miss all the best opportunities?

That’s why we scour hundreds of value stock ideas for you. Whenever we find something interesting, we send it straight to your inbox.

Subscribe free to Value Investor Daily with one click so you never miss out on our research again.